Literature DB >> 23352894

Leukocyte cell-derived chemotaxin 2 is a zinc-binding protein.

Akinori Okumura1, Takehiro Suzuki, Hideyuki Miyatake, Tomoya Okabe, Yuki Hashimoto, Takuya Miyakawa, Hai Zheng, Hiroyuki Unoki-Kubota, Hideaki Ohno, Naoshi Dohmae, Yasushi Kaburagi, Yoshitsugu Miyazaki, Masaru Tanokura, Satoshi Yamagoe.   

Abstract

Leukocyte cell-derived chemotaxin 2 (LECT2) is a secreted hepatic protein that has been associated with several physiological activities. LECT2 belongs to the peptidase M23 family, suggesting that it is a zinc-binding protein. To test this possibility, electrospray ionization mass spectrometry and X-ray absorption fine-structure analysis were performed. Results of these experiments indicated that recombinant mouse LECT2 produced by an animal cell line contains a zinc atom. Furthermore, the recombinant LECT2 was found to be self-oligomerized by disulfide bonds in vitro, but this was suppressed by addition of zinc. These results indicated that zinc stabilizes the LECT2 structure.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352894     DOI: 10.1016/j.febslet.2013.01.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics.

Authors:  Samih H Nasr; Ahmet Dogan; Christopher P Larsen
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-14       Impact factor: 8.237

Review 2.  Leukocyte Cell-Derived Chemotaxin-2: It's Role in Pathophysiology and Future in Clinical Medicine.

Authors:  V Slowik; U Apte
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

3.  LECT2 Ameliorates Blood-Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway.

Authors:  Yuan-Jun Qin; Ke Xiao; Zheng Zhong; Yin Zhao; Tian Yu; Xu-Fang Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

Review 4.  LECT2: A pleiotropic and promising hepatokine, from bench to bedside.

Authors:  Yuan Xie; Kai-Wei Fan; Shi-Xing Guan; Yang Hu; Yi Gao; Wei-Jie Zhou
Journal:  J Cell Mol Med       Date:  2022-06-03       Impact factor: 5.295

5.  Loss of bound zinc facilitates amyloid fibril formation of leukocyte-cell-derived chemotaxin 2 (LECT2).

Authors:  Jeung-Hoi Ha; Ho-Chou Tu; Stephan Wilkens; Stewart N Loh
Journal:  J Biol Chem       Date:  2021-02-20       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.